It is there. Okay, great.
Those points are consistent with our submission--in particular, speedier action, regulatory action on those substances that are the most serious, those that have the most serious criteria, and mandatory timelines for that action to be taken. To us, that's really the only way we can continue the momentum that was created by the achievement of this exercise.
In view of the time constraints, I'll turn over the conclusion of our presentation to Aaron Freeman.